Cargando…

From Co-Administration to Co-Formulation: The Race for New Vaccines against COVID-19 and Other Respiratory Viruses

Detalles Bibliográficos
Autor principal:	Focosi, Daniele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860680/ https://www.ncbi.nlm.nih.gov/pubmed/36679954 http://dx.doi.org/10.3390/vaccines11010109

Ejemplares similares

Second-Generation SARS-CoV-2 Recombinants: Lessons from Other Viruses
por: Focosi, Daniele, et al.
Publicado: (2023)

Antibodies and SARS-CoV-2: New Data on Diagnostics and Therapeutics
por: Focosi, Daniele, et al.
Publicado: (2022)

SARS-CoV-2: Advances in Serological Methods and the Understanding of Antibody Escape
por: Focosi, Daniele, et al.
Publicado: (2023)

SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal Antibodies
por: Focosi, Daniele, et al.
Publicado: (2021)

How SARS-CoV-2 Big Data Are Challenging Viral Taxonomy Rules
por: Focosi, Daniele, et al.
Publicado: (2023)

COVID-19 vaccines: A race against time
por: Peiffer-Smadja, Nathan, et al.
Publicado: (2021)

Respiratory delivery of passive immunotherapies for SARS-CoV-2 prophylaxis and therapy
por: Focosi, Daniele, et al.
Publicado: (2023)

SARS-CoV-2 BA.2.86 (“Pirola”): Is it Pi or Just Another Omicron Sublineage?
por: Focosi, Daniele, et al.
Publicado: (2023)

SARS-CoV-2 infection, vaccination and acquired hemophilia: Reply
por: Franchini, Massimo, et al.
Publicado: (2023)

WHO Is Recommending against the Use of COVID-19 Convalescent Plasma in Immunocompromised Patients?
por: Franchini, Massimo, et al.
Publicado: (2023)

Spike mutations in SARS-CoV-2 AY sublineages of the Delta variant of concern: implications for the future of the pandemic
por: Focosi, Daniele, et al.
Publicado: (2022)

The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation
por: Wang, Jieliang, et al.
Publicado: (2020)

Race for a COVID-19 vaccine
Publicado: (2020)

Virus against virus: a potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses
por: Nguyen, Tuan M., et al.
Publicado: (2020)

Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence
por: Focosi, Daniele, et al.
Publicado: (2022)

Co-Infections with Influenza and Other Respiratory Viruses
por: Stefanska, I., et al.
Publicado: (2012)

The investigation of mRNA vaccines formulated in liposomes administrated in multiple routes against SARS-CoV-2
por: Huang, Hai, et al.
Publicado: (2021)

Race with virus evolution: The development and application of mRNA vaccines against SARS-CoV-2
por: Lee, Kuo-Ming, et al.
Publicado: (2023)

Thrombotic thrombocytopenic purpura and other immune-mediated blood disorders following vaccination against SARS-CoV-2
por: Mannucci, Pier Mannuccio
Publicado: (2021)

Association between SARS-CoV-2 infection or vaccination and acquired hemophilia A: A case report and literature update
por: Franchini, Massimo, et al.
Publicado: (2023)

Immunoprophylaxis against respiratory syncytial virus with palvizumab: what is new?
por: Sáfadi, Marco Aurélio P.
Publicado: (2014)

Monoclonal antibody therapies against SARS-CoV-2
por: Focosi, Daniele, et al.
Publicado: (2022)

Prescription of Anti-Spike Monoclonal Antibodies in COVID-19 Patients with Resistant SARS-CoV-2 Variants in Italy
por: Focosi, Daniele, et al.
Publicado: (2022)

COVID-19 patient with B cell lymphoma co-morbidity managed with co-administration of ayurvedic formulation
por: Dilip Pandkar, Prasad, et al.
Publicado: (2022)

Possible effect of the “original antigenic sin” in vaccination against new variants of SARS-CoV-2()
por: Reina, J.
Publicado: (2022)

Covariation in the recognition of own-race and other-race faces argues against the role of group bias in the other race effect
por: Wang, Ao, et al.
Publicado: (2022)

Recombination in Coronaviruses, with a Focus on SARS-CoV-2
por: Focosi, Daniele, et al.
Publicado: (2022)

Co-infection of SARS-CoV-2 with other respiratory viruses and performance of lower respiratory tract samples for the diagnosis of COVID-19
por: Burrel, Sonia, et al.
Publicado: (2021)

A New Danger to the Race
Publicado: (1883)

Vaccination against SARS-CoV-2 should be included in childhood vaccination programs
por: Petersen, Eskild, et al.
Publicado: (2021)

Advanced Molecular Tweezers with Lipid Anchors against SARS-CoV-2 and Other Respiratory Viruses
por: Weil, Tatjana, et al.
Publicado: (2022)

Should we vaccinate children against SARS-CoV-2?
por: The Lancet Infectious Diseases
Publicado: (2021)

Racing for a SARS‐CoV‐2 vaccine
por: Türeci, Özlem, et al.
Publicado: (2021)

Amphotericin B Formulations and Other Drugs for Visceral Leishmaniasis
por: Berman, Jonathan
Publicado: (2015)

The Road towards Polyclonal Anti-SARS-CoV-2 Immunoglobulins (Hyperimmune Serum) for Passive Immunization in COVID-19
por: Focosi, Daniele, et al.
Publicado: (2021)

Vaccination of Older Adults Against Respiratory Syncytial Virus: The Final Pieces of the Puzzle
por: Atkins, Katherine E, et al.
Publicado: (2023)

Virus interference in CoViD-19
por: Chiappelli, Francesco, et al.
Publicado: (2022)

Durability of Immunity to SARS-CoV-2 and Other Respiratory Viruses
por: Siggins, Matthew K., et al.
Publicado: (2021)

Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19
por: Sharun, Khan, et al.
Publicado: (2020)

Vaccines against RNA Viruses
por: Saiz, Juan-Carlos
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mrddkoiravti3oocbijio2vq7u